Impact of antibiotic resistance on clinical outcomes and the cost of care.
about
Cost effectiveness in treating ventilator-associated pneumoniaUnresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites.Effect of duplicate isolates of methicillin-susceptible and methicillin-resistant Staphylococcus aureus on antibiogram data.Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies.Informed switching strongly decreases the prevalence of antibiotic resistance in hospital wards.Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia.Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistanceEcological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitalsAcinetobacter outbreaks, 1977-2000.Influence of provider and urgent care density across different socioeconomic strata on outpatient antibiotic prescribing in the USA.Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study.Clinically Relevant Growth Conditions Alter Acinetobacter baumannii Antibiotic Susceptibility and Promote Identification of Novel Antibacterial Agents.Laser-Generated Shockwaves as a Treatment to Reduce Bacterial Load and Disrupt Biofilm.Efflux-mediated antimicrobial resistance.Appropriate and timely empirical antimicrobial treatment of icu infections--a role for carbapenems.White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogensMethicillin-resistant Staphylococcus aureus in a Canadian intensive care unit: Delays in initiating effective therapy due to the low prevalence of infection.Ampicillin resistance and outcome differences in acute antepartum pyelonephritis.Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.The potential role of nemonoxacin for treatment of common infections.Seasonality of antibiotic prescriptions for outpatients and resistance genes in sewers and wastewater treatment plant outflow.Lipase-Sensitive Transfersomes Based on Photosensitizer/Polymerizable Lipid Conjugate for Selective Antimicrobial Photodynamic Therapy of Acne.The Threat and Response to Infectious Diseases (Revised).Clinico-microbiological study of Pseudomonas aeruginosa in wound infections and the detection of metallo-β-lactamase production.Colorimetric-plate method for rapid disk diffusion susceptibility testing of Escherichia coli.Impact of intensive care unit-acquired infection on hospital mortality in Japan: A multicenter cohort study.Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized studyA prospective observational study of the effect of penicillin skin testing on antibiotic use in the intensive care unit.Impact of antibiotics on conjugational resistance gene transfer in Staphylococcus aureus in sewage.A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price?Measuring Impact of Antimicrobial Resistance.The use of economic modeling to determine the hospital costs associated with nosocomial infections.Health implications of antimicrobial resistance for patients with acute kidney injury and bloodstream infection.Differences in antibiotic prescribing patterns between general practitioners in Scandinavia: a questionnaire study.Antibiotic lock-technique for the treatment of catheter-related bloodstream infections.The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States.
P2860
Q24796271-687B107C-F101-4232-A930-3FD0710FAB0EQ28468760-3B50581D-599F-4690-9AB3-34D00C081C18Q33193753-B3975D5A-7A6A-41E8-9DCD-748A9D8F69CEQ33237577-FE10CA95-8113-4ABB-8383-04CBA085ECFBQ33842121-BB55EBB7-036C-463F-8DC4-C720CEF944DEQ33935336-49AA491F-7A7E-4129-8218-6B432F1FFF23Q34064473-86326912-0B84-4DD9-B8D1-41805D649BDCQ34102811-B1404534-6038-4BB8-BF39-09F7F82088FCQ34340879-8A9A0C91-4694-49BF-A2B7-B44C6A2DA5BFQ35119005-4C6C5591-5539-4DD7-BA7C-DDE085F705FEQ35432752-87027CB9-5BEC-4842-87F1-A28361E904F4Q35567016-04480463-A69E-422A-AEE2-0C2587B34F6BQ35838503-FE4FC66B-A7F0-45EC-BC20-A3D6C1F8D9D0Q36057086-3464322B-D382-47D3-B8CF-398169DAAEDBQ36138147-E980002E-3947-40DE-A823-E94CF50213E8Q36219506-30A56BF0-1316-48D0-8164-F169C80A7F1BQ36854025-764038AC-4B6A-453E-8600-A89B182CB827Q36871014-062A8CFF-F7CF-435D-963E-F50F3D8871D6Q36932303-E4632D0C-2546-4DA8-8ACA-2654DAFB7889Q37302581-4B50AE2D-0F81-4698-8A32-160AF310D0B2Q37842543-BCFDC096-4BAF-4251-BF70-35FFA0CC0770Q39854828-E6DBF516-CAF9-402C-A505-BDC9CEA92B85Q40445277-14F4F15B-C8E0-4EAD-961C-FEF1E99B7A44Q40592880-CBB3909A-10F2-40D0-A454-80F773FA6E6AQ40931739-627C0678-9EAA-436D-B678-B6CD0F3FA402Q41866259-83D4C38F-0858-4285-A390-9FD13E8EEA70Q42756940-F77B7BE6-92A0-4F70-88A8-65932389A2A0Q43694841-96FF4C0E-2114-4180-8E94-0DBA9F5A1197Q44464881-71D15246-5791-454C-83C7-5D8B566A8816Q44518714-4C642E3D-6977-44A2-B12E-F7FD2B6DE97DQ44930328-1E3C8E38-886C-49D4-B810-206B4A09ABC4Q45972822-017B17A6-4301-48E6-8CA9-B98FFAA2D9EBQ47887562-1124DE40-5B12-4531-A8E2-B8BA469B933DQ49041403-9D53CE51-81A8-434A-9046-F6757E744B60Q51703598-9748324F-35FE-479F-8F5E-506D8BD2C7F9Q53860782-B0687711-B4FF-438E-8DE0-0607400208BCQ54417681-C591985B-0418-4435-A543-5F60DBDB656F
P2860
Impact of antibiotic resistance on clinical outcomes and the cost of care.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Impact of antibiotic resistance on clinical outcomes and the cost of care.
@ast
Impact of antibiotic resistance on clinical outcomes and the cost of care.
@en
Impact of antibiotic resistance on clinical outcomes and the cost of care.
@nl
type
label
Impact of antibiotic resistance on clinical outcomes and the cost of care.
@ast
Impact of antibiotic resistance on clinical outcomes and the cost of care.
@en
Impact of antibiotic resistance on clinical outcomes and the cost of care.
@nl
prefLabel
Impact of antibiotic resistance on clinical outcomes and the cost of care.
@ast
Impact of antibiotic resistance on clinical outcomes and the cost of care.
@en
Impact of antibiotic resistance on clinical outcomes and the cost of care.
@nl
P1476
Impact of antibiotic resistance on clinical outcomes and the cost of care.
@en
P2093
Niederman MS
P304
P356
10.1097/00003246-200104001-00011
P407
P433
P577
2001-04-01T00:00:00Z